The Global Human Chorionic Gonadotropin (hCG) Market was valued at USD 2,053.42 Million in 2023 and is projected to reach USD 3,276.67 Million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 8.10% during the forecast period (2024–2029). This robust growth is primarily driven by the increasing prevalence of infertility, rising demand for assisted reproductive technologies (ART), and expanding applications of hCG in weight loss and hormone therapy.

As the global healthcare landscape focuses on innovative fertility solutions and endocrine treatments, the key pharmaceutical companies developing and supplying hCG are at the forefront of this medical evolution. This blog profiles the Top 10 Companies in the Human Chorionic Gonadotropin Industry—a combination of established pharmaceutical giants and specialized biotech firms leading the way in reproductive health.

Download FREE Sample Report:
Global Human Chorionic Gonadotropin Market – View in Detailed Research Report

---

🔟 1. Merck & Co., Inc. (MSD)

Headquarters: Rahway, New Jersey, USA
Key Offering: Novarel (Chorionic Gonadotropin for Injection, USP)

Merck & Co. is a global healthcare leader with a strong portfolio in fertility treatments. Its product, Novarel, is a purified preparation of hCG used for inducing ovulation and pregnancy in anovulatory, infertile women, and for the treatment of hypogonadism in men. The company’s extensive R&D and global distribution network make it a dominant force in the hCG market.

Innovation and Development Focus:

• Continuous investment in fertility and endocrine research

• Global clinical trials for expanding hCG therapeutic indications

• Strategic partnerships with fertility clinics worldwide

---

9️⃣ 2. Ferring Pharmaceuticals

Headquarters: Saint-Prex, Switzerland
Key Offering: Pregnyl (human chorionic gonadotropin)

Ferring Pharmaceuticals is a specialty biopharmaceutical group with a deep commitment to reproductive medicine and women’s health. Pregnyl, one of its flagship products, is a highly purified hCG used extensively in ART cycles. Ferring is renowned for its patient-centric approach and innovation in reproductive health.

Innovation and Development Focus:

• Pioneering research in recombinant fertility hormones

• Advancing personalized medicine approaches in ART

• Global initiatives to improve access to fertility treatments

---

8️⃣ 3. Fresenius Kabi

Headquarters: Bad Homburg, Germany
Key Offering: hCG Sterile Powder for Injection

Fresenius Kabi is a global healthcare company that specializes in medicines and technologies for infusion, transfusion, and clinical nutrition. Its hCG product is a critical component in fertility treatment protocols, known for its high quality and reliability. The company’s strong presence in hospitals and clinics supports its significant market share.

Innovation and Development Focus:

• Focus on biosimilars and cost-effective hormone therapies

• Investment in sustainable manufacturing processes

• Expansion in emerging markets with high growth potential

---

7️⃣ 4. Bristol Myers Squibb

Headquarters: New York, New York, USA
Key Offering: Prior portfolio included fertility products; maintains R&D in endocrine disorders.

While Bristol Myers Squibb is primarily known for its oncology and immunology portfolios, the company has a historical presence and ongoing research interest in hormonal therapies. Its vast research capabilities and experience in complex biologics contribute to the broader advancement of treatments like hCG, often through partnerships and legacy product support.

Innovation and Development Focus:

• Biologics and novel therapeutic platform development

• Strategic acquisitions and partnerships in specialty care

• R&D in endocrine-related pathways with potential hCG applications

Download FREE Sample Report:
Global Human Chorionic Gonadotropin Market – View in Detailed Research Report

---

6️⃣ 5. Sun Pharmaceutical Industries Ltd.

Headquarters: Mumbai, Maharashtra, India
Key Offering: Generic hCG formulations

Sun Pharma is one of the world’s largest specialty generic pharmaceutical companies. It offers a range of affordable hCG products, making fertility treatments more accessible, particularly in cost-sensitive markets. The company’s robust manufacturing infrastructure and wide distribution network across Asia, Africa, and Latin America are key strengths.

Innovation and Development Focus:

• Development and marketing of high-quality, cost-effective generics

• Expansion of its specialty and branded generics portfolio

• Focus on increasing accessibility in high-growth emerging economies

---

5️⃣ 6. Sanzyme Biologics (A Subsidiary of UniChem Laboratories Ltd.)

Headquarters: Hyderabad, Telangana, India
Key Offering: ZyHCG (Recombinant Human Chorionic Gonadotropin)

Sanzyme Biologics is a pioneer in biotechnology in India, specializing in recombinant proteins and probiotics. The company developed ZyHCG, India’s first recombinant hCG, which offers high purity and consistency compared to urinary-derived products. This positions Sanzyme as an innovative player in the biologics segment of the market.

Innovation and Development Focus:

• Leadership in recombinant technology for hormone production

• Focus on overcoming limitations of urinary-sourced hCG

• Strategic focus on the Asia-Pacific biologics market

---

4️⃣ 7. Livzon Pharmaceutical Group Inc.

Headquarters: Zhuhai, Guangdong, China
Key Offering: Lizu (Human Chorionic Gonadotropin for Injection)

Livzon is a leading Chinese pharmaceutical manufacturer with a significant footprint in the endocrine and reproductive health market. Its hCG product is widely used in fertility clinics across China and other Asian countries. The company benefits from the vast domestic market and increasing government support for the biopharmaceutical industry.

Innovation and Development Focus:

• Strong R&D in biopharmaceuticals and diagnostic reagents

• Expansion of its product line in reproductive medicine

• Capitalizing on growth within China’s healthcare sector

---

3️⃣ 8. Scripps Laboratories (A Part of Scripps Laboratories Inc.)

Headquarters: San Diego, California, USA
Key Offering: High-purity hCG for diagnostic and research use

Scripps Laboratories specializes in providing high-purity biological products for research, diagnostic, and therapeutic development. While not a mass-market therapeutic supplier, it is a critical player for the research community and diagnostic kit manufacturers, supplying the reference-grade hCG essential for assay development and clinical studies.

Innovation and Development Focus:

• Providing high-purity antigens and antibodies for diagnostics

• Supporting academic and pharmaceutical R&D

• Quality control and standardization of biological reagents

---

2️⃣ 9. BioGenetics Inc. (A specialized biotech firm)

Headquarters: Los Angeles, California, USA
Key Offering: Highly purified urinary-derived hCG

BioGenetics Inc. is a specialized biotechnology company focused on reproductive hormones. It utilizes advanced purification technologies to produce high-quality urinary-derived hCG, catering to a segment of the market that prefers this traditional source. The company’s focus on niche, high-quality production ensures a stable position.

Innovation and Development Focus:

• Advanced purification technologies for urinary hormones

• Niche market targeting specific clinical preferences

• Maintaining stringent quality standards for biologic products

---

1️⃣ 10. Lee BioSolutions, Inc.

Headquarters: Maryland Heights, Missouri, USA
Key Offering: Research-grade and bulk hCG

Lee BioSolutions is a leading manufacturer and global supplier of purified proteins and enzymes for diagnostic and research applications. The company provides high-quality hCG to diagnostic companies for use in pregnancy tests and immunoassays. Its role in the supply chain for diagnostics is vital for the broader hCG ecosystem.

Innovation and Development Focus:

• Large-scale production of purified proteins for diagnostics

• Custom protein purification services for industry partners

• Ensuring consistent supply for global diagnostic markets

---

🌍 Outlook: The Future of the Human Chorionic Gonadotropin Market is Driven by Innovation and Accessibility

The hCG market is experiencing a significant transformation, moving beyond traditional fertility applications into new therapeutic areas. The convergence of rising infertility rates, technological advancements in recombinant DNA technology, and increasing healthcare expenditure in emerging economies is creating a fertile ground for sustained growth.

📈 Key Trends Shaping the Market:

• Shift from urinary-derived to recombinant hCG due to higher purity and safety profiles.

• Expanding applications in male hypogonadism and weight management protocols.

• Growing demand for affordable generics, particularly in Asia-Pacific and Latin America.

• Increased investment in ART clinics and supportive government policies in developing nations.

Get Full Report Here:
Global Human Chorionic Gonadotropin Market – View in Detailed Research Report

The companies profiled are not just supplying a critical hormone; they are enabling family building, advancing endocrine science, and improving diagnostic capabilities worldwide, making them central to the future of global healthcare.